Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
In Vivo (Athens, Greece)|November 1, 1994
Is taxol a surrogate for a universal regulator of mitosis?M SuffnessCancer Chemotherapy and Pharmacology|January 1, 1978
New natural products of interest under development at the National Cancer InstituteJ Douros, M SuffnessRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
New natural products under development at the National Cancer InstituteJ Douros, M SuffnessRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The National Cancer Institute's Natural Products Antineoplastic Development ProgramJ Douros, M SuffnessCancer Treatment Reports|June 1, 1985
Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural productsJ C Marsh, R H Shoemaker, M SuffnessAntimicrobial Agents and Chemotherapy|August 1, 1982
Bruceantin, a potent amoebicide from a plant, Brucea antidysentericaF D Gillin, D S Reiner, M SuffnessJournal of Natural Products|October 1, 1993
The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agentsG M Cragg, S A Schepartz, M Suffness, et al.Journal of Medicinal Chemistry|April 1, 1987
A novel synthesis of colchicide and analogues from thiocolchicine and congeners: reevaluation of colchicide as a potential antitumor agentR Dumont, A Brossi, C F Chignell, et al.Journal of the National Cancer Institute|September 21, 1988
Cephalotaxine esters: antileukemic advance or therapeutic failure?J L Grem, B D Cheson, S A King, et al.Journal of Medicinal Chemistry|March 29, 1996
Antitumor agents. 163. Three-dimensional quantitative structure-activity relationship study of 4'-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approachS J Cho, A Tropsha, M Suffness, et al.Pageof 2